(EU 02/04, S. 40 ff.): Klein, A.; Jahreis, G.: Probiotika und deren modulierende Wirkungen auf das Immunsystem

Literatur:

1. Schrezenmeir, J.; de Vrese, M.: Probiotics, Prebiotics, and synbiotics – approaching a definition. Am. J. Clin. Nutr. 73 , 361S–364S

2. Lilly, D.M.; Stillwell, R.H.: Probiotics. Growth promoting factors produced by micro-organisms. Science 147 (1965), 747–748

3. Abschlussbericht der Arbeitsgruppe „Probiotische Mikroorganismenkulturen in Lebensmitteln“ am BGVV (1999)

4. Kailasapathy, K.; Chin, J.: Survival and therapeutic potential of Probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol. Cell Biol. 78 (2000), 80–88

5. Ouwenhand, A.C.; Kirjavainen, P.V.; Shortt, C.; Salminen, S.: Probiotics: Mechanisms and established effects. Int. Dairy J. 9 (1999), 43–52

6. Koop-Hoolihan, L.: Prophylactic and therapeutic uses of probiotics: A review. J. Am. Diet. Assoc. 101 (2001), 229–238, 241

7. Barefoot, S.F.; Klaenhammer, T.R.: Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl. Environ. Microbiol. 45 (1983), 1808–1812

8. Persin, C.: Probiotika. Hippokrates Verlag GmbH Stuttgart, ???? 13. Jahrgang (1998), 87–91

9. Frey, I.; Arrigoni, E.; Amadò, R.: Critical examination of pro- and prebiotics by human studies. Nutr. 25 (2001), 485–501

10. Salminen, S.; Bouley, C.; Boutron-Ruault, M.-C.; Cummings, J. H.; Franck, A.; Gibson, G. R.; Isolauri, E.; Moreau, M.-C.; Roberfroid, M.; Rowland, I.: Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80 (1998), S147–S171

11. De Vrese, M.; Schrezenmeir, J.: Probiotics and non-intestinal infectious conditions. Br. J. Nutr. 88 (Suppl. 1) (2002), S59–S66

12. Kießling, G.; Schneider, J.; Jahreis, G.: Long term consumption of fermented dairy products over six months increases HDL-cholesterol. Eur. J. Clin. Nutr 56 (2002), 843–849

13. Roberfroid, M.B.: Prebiotics and probiotics: are they functional foods? Am. J. Clin. Nutr. 71 (2000), 1682S–1687S

14. Kuhnt, K., Klein, A., Jahreis, G : Influence of a synbiotic yoghurt (Lactobacillus acidophilus 74-2, Bifidobacterium species 420 and 1 % oligofructose) on the absorption of calcium and magnesium. 9. Symposium “Vitamine und Zusatzstoffe in der Ernährung von Mensch und Tier” (im Druck)

15. Brandtzaeg, P.; Halstensen, T. S.; Kett, K.; Krajci, P.; Kvale, D.; Rognum, T. O.; Scott, H.; Sollid, L. M.: Immunbiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterol. 97 (1989), 1562–1584

16. Isolauri, E.; Sütas, Y.; Kankaanpää, P.; Arvilommi, H.; Salminen, S.: Probiotics: effects on immunity. Am. J. Clin. Nutr. 73 (2001), 444S–450S

17. Brandtzaeg, P.: Molecular and cellular aspects of the secretory immunglobulin system. Act. Path. Microbiol. Immunol. Scand. 103 (1995), 1–19

18. Kirjavainen, P. V.;Gibson, G. R.: Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann. Med. 31 (1999), 288–292

19. Gibson, G. R.; Macfarlane, G. T. (eds.): Human colonic bacteria: Role in Nutrition, Physiology and Pathology. Boca Raton F. L., CRC Press (1995)

20. Holzapfel, W. H.; Haberer, P.; Snel, J.; Schillinger, U.; Huis in’t Veld, J. H. J.: Overview of gut flora and probiotics. Int J. Food Microbiol. 41 (1998), 85–101

21. Ouwehand, A. C.; Isolauri, E.; Kirjavainen, P. V.; Salminen, S. J: Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiol. Letters 172 (1999b), 61–64

22. Mitsuoka, T.: Taxonomy and ecology of Bifidobacteria. Microflora 3 (1984), 11–28

23. Sudo, N.; Sawamura, S.; Tanaka, K.; Kubo, C.; Koga, Y.: The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159 (1997), 1739–1745

24. Isolauri, E.; Majamaa, H.; Arvola, T.; Rantala, I.; Virtanen, E.; Arvilommi, H.: Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterol. 105 (1993), 1643–1650

25. Moreau, M. C.; Nuyts, V.; Raibaud, P.: Effet de l’ingestion d’un lait fermenté avec Lactobacillus bulgaricus et Streptococcus thermophilus sur la stimulation de l´immunité de l’hôte : étude chez la souris axénique (Effect of the ingestion of a fermented milk on the stimulation of immunity in germ-free mice.) Cah. Decarbox. Nutr. Diét. 29 (1994), 341–347

26. Schiffrin, E. J.; Brassart, D.; Servin, A. L.; Rochat, F.; Donnet-Hughes, A: Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am. J. Clin. Nutr. 66 (1997), 515S–520S

27. Jahreis, G.; Vogelsang, H.; Kiessling, G.; Schubert, R.; Hammes, W. P.: Influence of probiotic sausage (Lactobacillus paracasei) on blood lipids and immunological parameters of healthy volunteers. Food Res. Int. 35 (2002), 133–138

28. Donnet-Hughes, A.; Rochat, F.; Serrant, O.; Aeschlimann, J. M.; Schiffrin, E. J.: Modulation of nonspecific mechanisms of defense by lactic acid bacteria : effective dose. J. Dairy Sci. 82 (1999), 863–869

29. Pelto, L.; Isolauri, E.; Lilius, E.-M.; Nuutila, J.; Salminen, S. : Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin. Exp. Allergy 28 (1998), 1474–1479

30. Isolauri, E.; Arvola, T.; Sütas, Y.; Moilanen, E.; Salminen, S.: Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30 (2000), 1604–1610

31. Kalliomäki, M.; Salminen, S.; Arvilommi, H.; Kero, P.; Koskinen, P.; Isolauri, E.: Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 (2001), 1076–1079

32. Pessi, T.; Sütas, Y.; Hurme, M.; Isolauri, E.: Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy 30 (2000), 1804–1808

33. De Roos, N. M.; Katan, M. B.: Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am. J. Clin. Nutr. 71 (2000), 405–411

34. Van Niel, C. W.; Feudtner, C. W.; Garrison, M. M.; Cristakis, D. A.: Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109 (2002), 678–684

35. Kaila, M.; Isolauri, E.; Saxelin, M.; Arvilommi, H.; Vesikari; T.: Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch. Dis. Child. 72 (1995), 51–53

36. Kaila, M.; Isolauri, E.; Virtanen, E.; Laine, S.; Arvilommi, H.: Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res. 32 (1992), 141–144

37. Majamaa, M.; Isolauri, E.; Saxelin, M.; Vesikari, T.: Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 20 (1995), 333–338

38. Chandra, R. K: Effect of Lactobacillus on the incidence and severity of acute rotavirus diarrhoea in infants. A prospective placebo-controlled double-blind study. Nutr. Res. 22 (2002), 65–69

39. Cremonini, F.; Di Caro, S.; Nista, E. C.; Bartolozzi, F.; Capelli, G.; Gasbarrini, G.; Gasbarrini, A.: Meta-analysis: the effect of probiotic administration on antibiotic associated diarrhoea. Aliment. Pharmacol. Ther. 16 (2002), 1461–1467

40. D’Souza, A. L.; Rajkumar, C.; Cooke, J.; Bulpitt, C. J.: Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. Br. Med. J. 324 (2002), 1361–1366

41. Marteau, P. R.; de Vrese, M.; Cellier, C. J.; Schrezenmeir, J.: Protection from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr. 73 (2001), 430S–436S

42. Isolauri, E.; Kirjavainen, P. V.; Salminen, S.: Probiotics: a role in the treatment of intestinal infection and inflammation. Gut 50 (2002), iii54–iii59

43. Fabia, R.; Ar’Rajab, A.; Johansson, M. L.: Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat. Digestion 54 (1993), 248–255

44. Favier, C.; Neut, C.; Mizon, C.; Cortot, A.; Colombel, J. F.; Mizon, J.: Fecal &946;-D-galactosidase production and bifidobacteria are decreased in Crohn’s disease. Dig. Dis. Sci 42 (1997), 817–822

45. Ruseler van Embden, J. G. H.; Schouten, W. R.; Van Lieshout, L. M. C.: Pouchitis: result of microbial imbalance? Gut 35 (1994), 658–664

46. Gionchetti, P.; Rizzello, F.; Venturi, A.; Campieri M.: Probiotics in infective diarrhoea and inflammatory bowel disease. J. Gastroenterol. Hepatol. 15 (2000), 489–493

47. Lesourd, B. M.; Mazari, L.; Ferry, M.: The role of nutrition in immunity in the aged. Nutr. Rev. 56 (1998), 113–125

48. Lesourd, B. M.: Protein undernutrition as the major cause of decreased immune function in the elderly: clinical and functional implications. Nutr. Rev. 56 (1995), 86–92

49. Wenisch, C.; Patruta, S.; Daxbock, F.; Krause, R.; Horl, W.: Effect of age on human neutrophil function. J. Leukoc. Biol. 67 (2000), 40–45

50. Solana, R.; Mariani, E.: NK and NK/T cells in human senescence. Vaccine 18 (2000), 1613–1620

51. Gill, H. S.; Rutherfurd, K.; Gopal, P. K.; Cross, M. L.: Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J. Clin. Nutr. 74 (2001), 833–839

52. Sarker, S. A.; Gyr, K.: Non-immunological defence mechanisms of the gut. Gut 33 (1992), 987–993

53. Spanhaak, S.; Havenaar, R.; Schaafsma, G.: The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur. J. Clin. Nutr. 52 (1998), 899–907

54. Malin, M.; Suomalainen, H.; Saxelin, M.; Isolauri, E.: Promotion of IgA immune response in patients with Crohn’s disease by oral bacteriotherapy with Lactobacillus GG. Ann. Nutr. Metab. 40 (1996), 137–145

55. Rembacken, B. J.; Snelling, A. M.; Hawkey P. M., Chalmers, D. M.; Axon, A. T. R.: Non-pathogenic Escherichia coli verus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354 (1999), 635–639

56. Gionchetti, P.; Rizzello, F.; Venturi, A.; Brigidi, P.; Matteuzi, D.; Mazzocchi, G.; Poggioli, G.; Miglioli, M.; Campieri, M.: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double blind, placebo-controlled trial. Gastroenterol. 119 (2000), 305–309

57. Pantera, C.; Scrivano, M. L.; Falasco, G.; Andreoli, A.; Luzi, C.: Ineffectivness of probiotics in preventing recurrence after resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut 51 (2002), 405–409

58. Gionchetti, P.; Rizzello, F.; Helwig, U.; Venturi, A.; Lammers, K. M.; Brigidi, P.; Vitali, B.; Poggioli, G.; Miglioli, M.; Campirei, M.: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterol. 124 (2003) Seite!

59. Arunachalam, K.; Gill, H. S.; Chandra, R. K.: Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur. J. Clin. Nutr. 54 (2000), 263–267

60. Chiang, B. L.; Sheih, Y. H.; Wang, L. H.; Liao, C.K.: Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur. J. Clin. Nutr. 54 (2000), 849–855

61. Gill, H. S.; Cross, M. L.; Rutherfurd, K. J.; Gopal, P. K.: Dietary probiotic supplementation to enhance cellular immunity in the elderly. Br. J. Biomed. Sci. 58 (2001b), 94–96

62. Gill,H. S.; Rutherfurd, K. J.; Cross, M. L.: Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J. Clin. Immunol. 21 (2001), 264–271

63. Sheih, Y. H.; Chiang, B. L.; Wang, L. H.; Liao, C. K.; Gill, H. S.: Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J. Am. Coll. Nutr. 20 (2001), 149–156